Quilvest Acquires Majority Interest in UrgentMED

Quilvest Capital Partners (“Quilvest”), a leading global private investment firm, is announced that it has made a substantial growth investment in UrgentMED, the premier independent network of urgent care clinics in Southern California. Quilvest is partnering with UrgentMED’s co-founders, Dr. Jacob Rastegar, Dr. Morris Kokhab, and Dr. Pejman Bolourian, who will each remain significant shareholders and will continue to lead the business going forward.  The financial terms of the transaction were not disclosed.

Founded in 2007 and headquartered in West Hollywood, California, UrgentMED operates 35 urgent care clinics in the Southern California region, including Los Angeles County, Orange County and Ventura County.

“We are thrilled to partner with Drs. Rastegar, Kokhab and Bolourian,” said Jay Takefman, Partner and Co-Head of Direct Private Equity at Quilvest. “UrgentMED has established itself as the leading independent urgent care network in Southern California and is ideally positioned to meet consumers’ and payors’ demands for convenient, affordable and high-quality care by deploying its broad healthcare offering across its clinic footprint. We look forward to joining UrgentMED on the next phase of its journey as the company continues its growth strategy,” he added.

Dr. Rastegar, Dr. Kokhab and Dr. Bolourian (co-founders and co-CEOs), stated: “We welcome the Quilvest team to the UrgentMED family. Quilvest is an ideal partner for us due to its deep understanding of multi-unit business models, healthcare sector expertise and vast network of resources to help us grow.  We are excited to have a supportive partner who shares our vision.”

Benjamin Sass, Principal at Quilvest, added: “UrgentMED is an exceptional business led by an exceptional team. We look forward to helping UrgentMED accelerate its expansion strategy, while continuing to leverage UrgentMED’s patient-centric model and culture of care.”

Quilvest was advised by Piper Sandler and Dechert LLP. UrgentMED was advised by FocalPoint Securities LLC and Sheppard, Mullin, Richter & Hampton.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy